Phrenic Nerve Injury During Cryoballoon-Based Pulmonary Vein Isolation: Results of the Worldwide YETI Registry.


Journal

Circulation. Arrhythmia and electrophysiology
ISSN: 1941-3084
Titre abrégé: Circ Arrhythm Electrophysiol
Pays: United States
ID NLM: 101474365

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 29 12 2021
medline: 1 3 2022
entrez: 28 12 2021
Statut: ppublish

Résumé

Cryoballoon-based pulmonary vein isolation (PVI) has emerged as an effective treatment for atrial fibrillation. The most frequent complication during cryoballoon-based PVI is phrenic nerve injury (PNI). However, data on PNI are scarce. The YETI registry is a retrospective, multicenter, and multinational registry evaluating the incidence, characteristics, prognostic factors for PNI recovery and follow-up data of patients with PNI during cryoballoon-based PVI. Experienced electrophysiological centers were invited to participate. All patients with PNI during CB2 or third (CB3) and fourth-generation cryoballoon (CB4)-based PVI were eligible. A total of 17 356 patients underwent cryoballoon-based PVI in 33 centers from 10 countries. A total of 731 (4.2%) patients experienced PNI. The mean time to PNI was 127.7±50.4 seconds, and the mean temperature at the time of PNI was -49±8°C. At the end of the procedure, PNI recovered in 394/731 patients (53.9%). Recovery of PNI at 12 months of follow-up was found in 97.0% of patients (682/703, with 28 patients lost to follow-up). A total of 16/703 (2.3%) reported symptomatic PNI. Only 0.06% of the overall population showed symptomatic and permanent PNI. Prognostic factors improving PNI recovery are immediate stop at PNI by double-stop technique and utilization of a bonus-freeze protocol. Age, cryoballoon temperature at PNI, and compound motor action potential amplitude loss >30% were identified as factors decreasing PNI recovery. Based on these parameters, a score was calculated. The YETI score has a numerical value that will directly represent the probability of a specific patient of recovering from PNI within 12 months. The incidence of PNI during cryoballoon-based PVI was 4.2%. Overall 97% of PNI recovered within 12 months. Symptomatic and permanent PNI is exceedingly rare in patients after cryoballoon-based PVI. The YETI score estimates the prognosis after iatrogenic cryoballoon-derived PNI. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03645577. Graphic Abstract: A graphic abstract is available for this article.

Sections du résumé

BACKGROUND
Cryoballoon-based pulmonary vein isolation (PVI) has emerged as an effective treatment for atrial fibrillation. The most frequent complication during cryoballoon-based PVI is phrenic nerve injury (PNI). However, data on PNI are scarce.
METHODS
The YETI registry is a retrospective, multicenter, and multinational registry evaluating the incidence, characteristics, prognostic factors for PNI recovery and follow-up data of patients with PNI during cryoballoon-based PVI. Experienced electrophysiological centers were invited to participate. All patients with PNI during CB2 or third (CB3) and fourth-generation cryoballoon (CB4)-based PVI were eligible.
RESULTS
A total of 17 356 patients underwent cryoballoon-based PVI in 33 centers from 10 countries. A total of 731 (4.2%) patients experienced PNI. The mean time to PNI was 127.7±50.4 seconds, and the mean temperature at the time of PNI was -49±8°C. At the end of the procedure, PNI recovered in 394/731 patients (53.9%). Recovery of PNI at 12 months of follow-up was found in 97.0% of patients (682/703, with 28 patients lost to follow-up). A total of 16/703 (2.3%) reported symptomatic PNI. Only 0.06% of the overall population showed symptomatic and permanent PNI. Prognostic factors improving PNI recovery are immediate stop at PNI by double-stop technique and utilization of a bonus-freeze protocol. Age, cryoballoon temperature at PNI, and compound motor action potential amplitude loss >30% were identified as factors decreasing PNI recovery. Based on these parameters, a score was calculated. The YETI score has a numerical value that will directly represent the probability of a specific patient of recovering from PNI within 12 months.
CONCLUSIONS
The incidence of PNI during cryoballoon-based PVI was 4.2%. Overall 97% of PNI recovered within 12 months. Symptomatic and permanent PNI is exceedingly rare in patients after cryoballoon-based PVI. The YETI score estimates the prognosis after iatrogenic cryoballoon-derived PNI. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03645577. Graphic Abstract: A graphic abstract is available for this article.

Identifiants

pubmed: 34962134
doi: 10.1161/CIRCEP.121.010516
pmc: PMC8772436
doi:

Banques de données

ClinicalTrials.gov
['NCT03645577']

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e010516

Commentaires et corrections

Type : CommentIn

Références

Heart Rhythm. 2018 Sep;15(9):1348-1355
pubmed: 29684571
Europace. 2018 Sep 1;20(9):1459-1467
pubmed: 29016779
Clin Res Cardiol. 2016 Jun;105(6):482-8
pubmed: 26608161
J Cardiovasc Electrophysiol. 2014 Feb;25(2):187-94
pubmed: 24102792
Heart Rhythm. 2013 Sep;10(9):1318-24
pubmed: 23891574
Europace. 2018 Oct 1;20(10):e156-e163
pubmed: 29182748
Heart Rhythm. 2015 Jul;12(7):1658-66
pubmed: 25778428
Europace. 2015 Apr;17(4):574-8
pubmed: 25564551
N Engl J Med. 2016 Jun 9;374(23):2235-45
pubmed: 27042964
Circ Arrhythm Electrophysiol. 2015 Apr;8(2):303-7
pubmed: 25740826
Europace. 2015 May;17(5):725-31
pubmed: 25618741
Clin Res Cardiol. 2016 Sep;105(9):774-82
pubmed: 27085722
J Cardiovasc Electrophysiol. 2020 Aug;31(8):1932-1941
pubmed: 32419183
Heart Rhythm. 2016 Dec;13(12):2306-2313
pubmed: 27503480
Circ Arrhythm Electrophysiol. 2014 Apr;7(2):288-92
pubmed: 24610797
J Cardiovasc Electrophysiol. 2015 May;26(5):493-500
pubmed: 25644659
Europace. 2019 Sep 1;21(9):1313-1324
pubmed: 31199860
Int J Cardiol. 2018 Sep 1;266:106-111
pubmed: 29887425
Int J Cardiol. 2020 Aug 1;312:73-80
pubmed: 32241572
Heart Rhythm. 2017 Apr;14(4):495-500
pubmed: 27956248
J Cardiovasc Electrophysiol. 2014 May;25(5):466-470
pubmed: 24400647
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Europace. 2015 Jun;17(6):884-90
pubmed: 25488959
Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1088-94
pubmed: 26338833
Circulation. 2019 Nov 26;140(22):1779-1788
pubmed: 31630538
Cardiol J. 2019;26(4):368-374
pubmed: 29924380
Heart Rhythm. 2015 Apr;12(4):673-80
pubmed: 25542427
J Am Heart Assoc. 2018 Mar 24;7(7):
pubmed: 29574457

Auteurs

Christian-H Heeger (CH)

University Heart Center Lübeck, Medical Clinic II, Department of Cardiology, Angiology and Intensive Care Medicine, Germany (C.-H.H., A.G., K.-H.K., R.R.T.).
Asklepios Klinik St. Georg, Hamburg, Germany (C.-H.H., A.M., K.-H.K.).
German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Germany (C.-H.H., R.R.T.).

Christian Sohns (C)

Herz-und Diabeteszentrum NRW, Bad Oeynhausen, Germany (C.S., P.S.).

Alexander Pott (A)

Department of Cardiology, University of Ulm, Germany (A.P., T.D.).

Andreas Metzner (A)

Asklepios Klinik St. Georg, Hamburg, Germany (C.-H.H., A.M., K.-H.K.).
Asklepios Klinik Harburg, Hamburg, Germany (A.M.).
University Heart Center Hamburg, Germany (A.M.).

Osamu Inaba (O)

Japanese Red Cross Saitama Hospital, Saitama, Japan (O.I.).

Florian Straube (F)

München Klinik Bogenhausen und Schwabing, Klinik für Kardiologie und Internistische Intensivmedizin, München, Germany (F.S.).
Ludwig-Maximilians-University, Faculty Munich University Clinic, Germany (F.S.).

Malte Kuniss (M)

Kerckhoff Klinik, Bad Nauheim, Germany (M.K.).

Arash Aryana (A)

Mercy General Hospital and Dignity Health Heart and Vascular Institute, Sacramento, CA (A.A.).

Shinsuke Miyazaki (S)

Tsuchiura Kyodo Hospital, Ibaraki, Japan (S.M.).

Serkan Cay (S)

Department of Cardiology, Division of Arrhythmia and Electrophysiology, University of Health Sciences, Ankara City Hospital, Turkey (S.C.).

Joachim R Ehrlich (JR)

St. Josefs-Hospital, Wiesbaden, Germany (J.R.E.).

Ibrahim El-Battrawy (I)

Department of Cardiology and Angiology, Bergmannsheil University Hospitals, Ruhr University of Bochum, Germany (I.E.-B.).

Martin Martinek (M)

Ordensklinikum Linz Elisabethinen, Austria (M.M.).

Ardan M Saguner (AM)

Department of Cardiology, University Heart Center Zurich, University Hospital Zurich, Switzerland (A.M.S.).

Verena Tscholl (V)

Charité Campus Benjamin Franklin, Berlin, Germany (V.T.).

Kivanc Yalin (K)

İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey (K.Y.).

Evgeny Lyan (E)

Herzzentrum Bad Bevensen, Germany (E.L.).

Wilber Su (W)

University of Arizona, Phoenix (W.S.).

Giorgi Papiashvili (G)

Helsicore, Israeli-Georgian Medical Research Clinic, Tbilisia (G.P.).

Maichel Sobhy Naguib Botros (MSN)

Critical care department Cairo University, Cairo, Egypt (M.S.N.B.).

Alessio Gasperetti (A)

University Heart Center Lübeck, Medical Clinic II, Department of Cardiology, Angiology and Intensive Care Medicine, Germany (C.-H.H., A.G., K.-H.K., R.R.T.).
Department of Cardiology, Johns Hopkins University, Baltimore (A.G.).
Cardiology and Arrhythmology Clinic, Department of Biomedical Sciences and Public Health, University Hospital "Umberto I-Lancisi-Salesi", Marche Polytechnic University, Ancona, IT, Italy (A.G.).

Riccardo Proietti (R)

Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom (R.P.).

Erik Wissner (E)

Division of Cardiology, University of Illinois at Chicago (E.W.).

Masashi Kamioka (M)

Department of Cardiovascular Medicine, Fukushima Medical University, Japan (M.K.).

Hisaki Makimoto (H)

Universitätsklinik Düsseldorf, Abteilung für Kardiologie, Germany (H.M.).

Tsuyoshi Urushida (T)

Hamamatsu University School of Medicine, Japan (T.U.).

Tolga Aksu (T)

Kocaeli Derince Training and Research, Turkey (T.A.).

Julian K R Chun (JKR)

CCB/Med. Klinik III, Kardiologie, Markuskrankenhaus, Frankfurt am Main, Germany (J.K.R.C.).

Kudret Aytemir (K)

Arrhythmia and Electrophysiology Unit, Department of Cardiology, Hacettepe University, Ankara, Turkey (K.A.).

Ewa Jędrzejczyk-Patej (E)

Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Zabrze, Poland (E.J.-P.).

Karl-Heinz Kuck (KH)

University Heart Center Lübeck, Medical Clinic II, Department of Cardiology, Angiology and Intensive Care Medicine, Germany (C.-H.H., A.G., K.-H.K., R.R.T.).
Asklepios Klinik St. Georg, Hamburg, Germany (C.-H.H., A.M., K.-H.K.).
LANS Cardio, Hamburg, Germany (K.-H.K.).

Tillman Dahme (T)

Department of Cardiology, University of Ulm, Germany (A.P., T.D.).

Daniel Steven (D)

Universität zu Köln, Abteilung für Elektrophysiologie, Köln, Germany (D.S.).
University Hospital Graz, Austria (D.S.).

Philipp Sommer (P)

Herz-und Diabeteszentrum NRW, Bad Oeynhausen, Germany (C.S., P.S.).

Roland Richard Tilz (R)

University Heart Center Lübeck, Medical Clinic II, Department of Cardiology, Angiology and Intensive Care Medicine, Germany (C.-H.H., A.G., K.-H.K., R.R.T.).
German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Germany (C.-H.H., R.R.T.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH